Jul, 2010
News / Press Releases
Astellas to Pay $295 Million to Extend License of Regeneron's VelocImmune® Antibody Technology through 2023 (pdf 56KB)
Read More
News / Press Releases
Approval for Micamlo Combination Tablets AP Manufacturing and Distribution(pdf98 KB)
Read More
News / Press Releases
Contents of Stock Acquisition Rights(Stock Option Scheme as Stock-Linked Compensation Plan)(pdf34 KB)
Read More
News / Press Releases
Astellas Nominates President of OSI Pharmaceuticals, Inc. (pdf34 KB)
Read More
Apr, 2024
Apr, 2024
Feb, 2024
Nov, 2023
Mar, 2024
Feb, 2024
Oct, 2023
Sep, 2023
Nothing Found
Unfortunately, we weren't able to find a match for your search query. Please try again.
Nothing Found
Unfortunately, we weren't able to find a match.